10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel

CERE Insider Trading (Cerevel Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $5,275,357.04
Insider Selling (Last 12 Months): $0.00

Cerevel Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cerevel Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cerevel Therapeutics Share Price & Price History

Current Price: $25.04
Price Change: Price Increase of +0.1 (0.40%)
As of 07/29/2021 01:00 AM ET

This chart shows the closing price history over time for CERE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Three Cryptocurrencies to Hold in 2021
In 2021, Dogecoin went up over 12,000%. SafeMoon went up more than 20,000%...

But if you missed those gains, there is still time to get in on the digital currency boom.

Luke Lango – InvestorPlace’s resident crypto expert – just released the names of 3 tokens every investor should own in a free report.
Click here to claim your copy today.
pixel

Cerevel Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/7/2021Perceptive Advisors LlcDirectorBuy200,000$25.00$5,000,000.00View SEC Filing Icon  
6/17/2021Gabrielle SulzbergerDirectorBuy21,084$13.06$275,357.0435,354View SEC Filing Icon  
See Full Table
Insider Buying at Cerevel Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cerevel Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Cerevel Therapeutics (NASDAQ:CERE)

78.37% of Cerevel Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CERE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cerevel Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2021Millennium Management LLC426,016$5.85M0.0%+976.6%0.335%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.296,700$4.07M0.0%+147.3%0.233%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC261,504$3.59M0.0%+638.1%0.205%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley5,300$73K0.0%-63.2%0.004%Search for SEC Filing on Google Icon
5/18/2021Alyeska Investment Group L.P.1,012,480$13.90M0.2%-24.5%0.796%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC1,226,729$16.84M0.0%-11.2%0.964%Search for SEC Filing on Google Icon
5/18/2021Man Group plc13,468$0.19M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC13,002$0.18M0.0%N/A0.010%Search for SEC Filing on Google Icon
5/17/2021Perceptive Advisors LLC4,643,095$63.75M0.8%+2.2%3.643%Search for SEC Filing on Google Icon
5/17/2021Rock Springs Capital Management LP1,005,100$13.80M0.3%+0.6%0.791%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD3,399,888$46.68M0.0%+0.2%2.675%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP392,910$5.40M0.1%N/A0.309%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP33,368$0.46M0.0%N/A0.026%Search for SEC Filing on Google Icon
5/17/2021Brookfield Asset Management Inc.24,253$0.33M0.0%-33.3%0.019%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.912,240$12.53M1.0%+12.4%0.718%Search for SEC Filing on Google Icon
5/17/2021Ally Bridge Group NY LLC1,728,590$23.73M4.6%-2.2%1.360%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.190,266$2.61M0.0%+572.1%0.150%Search for SEC Filing on Google Icon
5/14/2021TD Asset Management Inc.114,715$1.58M0.0%+208.7%0.090%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG12,947$0.18M0.0%N/A0.010%Search for SEC Filing on Google Icon
5/13/2021Wolverine Asset Management LLC8,776$0.12M0.0%N/A0.007%Search for SEC Filing on Google Icon
5/13/2021Penserra Capital Management LLC14,762$0.20M0.0%-32.0%0.012%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp830,788$11.41M0.0%+3,739.7%0.654%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.104,273$1.43M0.0%+13.7%0.082%Search for SEC Filing on Google Icon
5/13/2021Federated Hermes Inc.1,950,000$26.77M0.1%+104.9%1.534%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp69,601$0.96M0.0%+5.8%0.055%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC443,791$6.09M0.0%-3.3%0.349%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.2,635$36K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/12/2021E Fund Management Co. Ltd.2,494$34K0.0%N/A0.002%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG8,403$0.12M0.0%-37.2%0.007%Search for SEC Filing on Google Icon
5/10/2021HighTower Advisors LLC66,544$0.91M0.0%+46.8%0.052%Search for SEC Filing on Google Icon
5/10/2021Rafferty Asset Management LLC61,585$0.85M0.0%N/A0.048%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,097,571$15.07M0.0%+0.2%0.863%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP22,500$0.37M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC21,003$0.36M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC15,478$0.26M0.0%N/A0.012%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.1,341,485$22.24M0.3%N/A1.055%Search for SEC Filing on Google Icon
2/18/2021Verition Fund Management LLC35,430$0.59M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/16/2021Alyeska Investment Group L.P.1,341,485$22.24M0.3%N/A1.055%Search for SEC Filing on Google Icon
2/16/2021Brookfield Asset Management Inc.36,355$0.60M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/16/2021Price T Rowe Associates Inc. MD3,392,133$54M0.0%N/A2.668%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP49,992$0.83M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.166,710$2.77M0.0%N/A0.131%Search for SEC Filing on Google Icon
2/12/2021Penserra Capital Management LLC21,701$0.36M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/12/2021Federated Hermes Inc.951,700$15.78M0.0%N/A0.749%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp65,805$1.09M0.0%N/A0.052%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.91,743$1.52M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/11/2021Artal Group S.A.2,282,100$37.84M0.8%N/A1.795%Search for SEC Filing on Google Icon
2/11/2021Monashee Investment Management LLC200,000$3.32M0.4%N/A0.157%Search for SEC Filing on Google Icon
2/10/2021HighTower Advisors LLC45,325$0.75M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp21,637$0.36M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.1,095,391$18.16M0.0%N/A0.862%Search for SEC Filing on Google Icon
1/29/2021Creative Planning13,401$0.22M0.0%N/A0.011%Search for SEC Filing on Google Icon
1/19/2021LGT Capital Partners LTD.144,254$2.39M0.1%N/A0.113%Search for SEC Filing on Google Icon
5/13/2016Sabby Management LLC720,378$0.16M0.0%+26.2%4.906%Search for SEC Filing on Google Icon
2/16/2016Frigate Ventures LP4,728,318$1.54M0.5%N/A32.198%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing CVL-231, a positive allosteric modulator (PAM) that is in Phase Ib clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase II proof-of-concept trials in drug-resistant focal onset seizures in epilepsy or focal onset epilepsy, as well as Phase I proof-of-principle trial for acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in Phase III clinical trials for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist for the treatment of dementia-related apathy; and CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I single ascending dose trials for the treatment of substance use disorder. It is also involved in the development of various preclinical portfolio for various neuroscience indications. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Read More on Cerevel Therapeutics

Today's Range

Now: $25.04
Low: $24.55
High: $25.23

50 Day Range

MA: $18.28
Low: $12.56
High: $29.69

52 Week Range

Now: $25.04
Low: $9.00
High: $31.09

Volume

376,543 shs

Average Volume

1,110,694 shs

Market Capitalization

$3.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cerevel Therapeutics?

Cerevel Therapeutics' top insider investors include:
  1. Gabrielle Sulzberger (Director)
  2. Perceptive Advisors Llc (Director)
10 Million People Started Trading Last Year – Here’s What to Do Next
How do you make money trading?
What are the secrets pros use to beat the market day after day?
Former Chicago Board Options Exchange trader reveals all the insider tricks...
Get the Full Report Now (No Credit Card Required... Limited Time Only)
pixel